目錄:杭州斯達(dá)特生物科技有限公司>>蛋白>>細(xì)胞因子>> UA040009IL-21 Protein, Human
參考價(jià) | ¥ 1080 |
參考價(jià) | ¥ 1080 |
更新時(shí)間:2025-06-16 16:33:44瀏覽次數(shù):20評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,,謝謝!
IL-21 (another common gamma chain cytokine) that is produced primarily by CD4+ T cells of the TFH lineage has a range of functions, including the promotion of apoptosis, proliferation, and gain of effector function in B cells, T cells, NK cells, and DC. After BMT, TFH cells drive marginal zone B cell expansion and aberrant B cell development. These B cells produce alloantibodies in a Bruton's tyrosine kinase (BTK)–dependent manner, and these antibodies are now established as making a critical contribution to cGVHD. IL-21 also induces IL-10 production and can thus have both regulatory and proinflammatory roles, depending on the other cytokines present. IL-21R deficient animals and specific blocking antibodies have been used to assess the role of IL-21 in GVHD, confirming it has a pathogenic role in the GI tract (with receptor-deficient animals experiencing less GI-specific GVHD). The use of IL-21 blocking mAb used in a xenogeneic mouse model (with NOD/SCID/γc?/- recipients) has demonstrated a decrease in CD8+ T cells and an increased proportion of Tregs. This group also demonstrated local protein expression of IL-21 in the GIT and skin, but not serum. Neutralization of IL-21 represents a promising therapeutic strategy to prevent and treat cGVHD that now requires investigation in a clinical study.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)